MOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.

BMC Biotechnology, a leading journal in the field of biotechnology, is published by BMC and has been a pivotal platform for open-access research since 2000. With a focus on the diverse areas of biotechnology, including biochemistry, genetics, and molecular biology, this journal holds a prestigious Q2 ranking in its category for 2023 and demonstrates a commendable percentile rank in the top 66th for its Scopus listings. Operating out of the United Kingdom and covering research from 2001 to 2024, BMC Biotechnology is committed to disseminating high-quality, rigorously peer-reviewed articles that foster advancements and innovations in the biotechnology landscape. Researchers, professionals, and students alike will benefit from the journal's rich content and dedicated commitment to enhancing scientific discourse within the realm of biotechnology.

BIOPROCESS AND BIOSYSTEMS ENGINEERING is a prestigious journal published by Springer, dedicated to advancing the field of bioengineering and biotechnology. Established in 1996, this influential journal provides a platform for disseminating high-quality research that covers a wide spectrum of topics related to bioprocessing, biosystems, and their applications in medicine and environmental engineering. With an impressive impact factor and ranking in the top quartile (Q2) across bioengineering, biotechnology, and miscellaneous medical fields, BIOPROCESS AND BIOSYSTEMS ENGINEERING stands out as a critical resource for researchers, professionals, and students. The journal is indexed in Scopus, reflecting its significant contribution to the scientific community, particularly with its robust percentile rankings (77th in Biotechnology and 70th in Bioengineering). Available in both print and electronic formats, this journal ensures accessible research for those pushing the boundaries of knowledge in bioprocessing and biosystems. As it continues to evolve, BIOPROCESS AND BIOSYSTEMS ENGINEERING encourages submissions that contribute to innovative research practices and applications, thereby fostering academic collaboration and advancement in this dynamic field.

ENGINEERING IN LIFE SCIENCES, published by Wiley, is a pivotal journal for professionals, researchers, and students dedicated to advancing the interdisciplinary fields of bioengineering, biotechnology, and environmental engineering. With an ISSN of 1618-0240 and an E-ISSN of 1618-2863, this journal has established itself as a reputable platform for disseminating innovative research findings and breakthroughs in engineering applications within the life sciences. Currently holding a prestigious Q2 ranking in multiple categories, including bioengineering and environmental engineering, it reflects a strong commitment to high-quality, impactful research (Scopus ranks: Environmental Science - Rank #61/197, Biochemistry, Genetics and Molecular Biology - Rank #112/311). The journal spans contributions from 2004 to 2024, ensuring a comprehensive archiving of evolving scientific discourse. Although it does not currently offer open access, its curated articles are accessible through institutional and single-article purchases, providing valuable insights and updates for the academic community. Join us in shaping the future of engineering within life sciences and stay informed on critical advancements that are driving innovation across multiple disciplines.

Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

TRENDS IN BIOTECHNOLOGY, published by CELL PRESS, stands as a premier journal since its inception in 1983, focusing on the dynamic and ever-evolving fields of bioengineering and biotechnology. With a notable impact factor and ranking in the top quartile (Q1) of its categories for 2023, this journal is recognized for its contribution to advancing scientific knowledge, boasting a Scopus rank of #5/311 in Biotechnology and #5/162 in Bioengineering, placing it in the 98th and 97th percentiles, respectively. Although it does not operate under an open access model, TRENDS IN BIOTECHNOLOGY ensures a rigorous peer-review process that provides a platform for high-quality research that influences both academic and industrial advancements. The journal's objectives encompass the dissemination of cutting-edge research findings, reviews, and insights that foster innovation in biotechnological applications, making it an invaluable resource for researchers, professionals, and students alike. With its broad scope across the intersection of biosciences and technology, TRENDS IN BIOTECHNOLOGY continues to lead discussions and developments that shape the future of the biotechnology landscape.

JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, published by Oxford University Press, is a vital resource for researchers and professionals actively engaged in the fields of applied microbiology, biotechnology, and bioengineering. With an ISSN of 1367-5435 and E-ISSN of 1476-5535, this journal has established itself as a leading platform for disseminating innovative research findings and advancing knowledge in industrial microbiology since its inception in 1996. As of 2023, it is classified in the Q2 quartile across multiple categories including Applied Microbiology and Biotechnology, Bioengineering, and Medicine, underscoring its significance in the academic community. Notably, it ranks 26th of 127 in Applied Microbiology and Biotechnology, placing it in the 79th percentile, indicative of its high impact and influence. Although it does not currently offer Open Access, it remains a key outlet for high-quality scholarly articles that align with the objectives of improving industrial practices through biotechnological applications. For those interested in the latest developments and methodologies within the realm of applied microbiology and biotechnology, this journal serves as an indispensable reference.

Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

Biochemistry and Cell Biology, published by Canadian Science Publishing, is a prestigious journal that has been instrumental in advancing the fields of biochemistry, molecular biology, and cell biology since its inception in 1986. With an impressive scope spanning innovative research findings to comprehensive reviews, this journal serves as a vital resource for researchers, professionals, and students alike. Currently positioned in the Q2 quartile in Biochemistry and Q3 quartiles in both Cell Biology and Molecular Biology, it reflects a robust contribution to scientific discourse, placing it among reputable publications in its field. The journal boasts notable rankings within the Scopus database, highlighting its impact and relevance, and continues to be a valuable platform for disseminating pivotal research. By providing access to a wide array of articles, the journal remains committed to fostering knowledge and collaboration in the scientific community.